Orhan Adalı
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Clinical Biochemistry top 5%
- Paraoxonase enzyme and polymorphisms
Papers in
-
- Glutathione Transferases and Polymorphisms 9
- Genomics, phytochemicals, and oxidative stress 7
- Metabolomics and Mass Spectrometry Studies 4
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Apelin-related biomedical research 2
- Co-authors
- Emel Arınç (13 shared papers)Serdar Karakurt (8 shared papers)Birsen Can Demirdöğen (13 shared papers)Şeref Demirkaya (10 shared papers)Şevki Arslan (5 shared papers)Semai Bek (6 shared papers)Alaattin Şen (7 shared papers)Aslı Semiz (5 shared papers)
- Journals
- Neurological Sciences (3 papers)Archives of Toxicology (3 papers)Cell Biochemistry and Function (2 papers)Neurological Research (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)
- Partner nations
- TürkiyeSerbiaUnited Kingdom
In The Last Decade
Orhan Adalı
42 papers receiving 628 citations
Peers
Comparison fields: 5 of 100
- Pharmacology 176
- Clinical Biochemistry 76
- Biochemistry 72
- Biochemistry 45
- Applied Microbiology and Biotechnology 12
Countries citing papers authored by Orhan Adalı
This map shows the geographic impact of Orhan Adalı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orhan Adalı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orhan Adalı more than expected).
Fields of papers citing papers by Orhan Adalı
This network shows the impact of papers produced by Orhan Adalı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orhan Adalı. The network helps show where Orhan Adalı may publish in the future.
Co-authors
The 25 scholars most cited alongside Orhan Adalı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 52 | |
| 2 | 2007 | 51 | |
| 3 | 2006 | 47 | |
| 4 | 2007 | 40 | |
| 5 | 2013 | 36 | |
| 6 | 2010 | 31 | |
| 7 | 2009 | 29 | |
| 8 | 2005 | 29 | |
| 9 | 2007 | 26 | |
| 10 | 2012 | 22 | |
| 11 | 2007 | 21 | |
| 12 | 1990 | 19 | |
| 13 | 2013 | 17 | |
| 14 | 1983 | 17 | |
| 15 | 2015 | 16 | |
| 16 | 2014 | 15 | |
| 17 | 2012 | 15 | |
| 18 | Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism. | 1998 | 15 |
| 19 | 2013 | 13 | |
| 20 | 1998 | 13 |
About Orhan Adalı
Orhan Adalı is a scholar working on Molecular Biology, Pharmacology, Oncology, Nutrition and Dietetics and Biochemistry, having authored 42 papers that have together received 654 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Glutathione Transferases and Polymorphisms (9 papers), Genomics, phytochemicals, and oxidative stress (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Pomegranate: compositions and health benefits (3 papers) and Apelin-related biomedical research (2 papers). The work is most often cited by research in Pharmacology (176 citations), Clinical Biochemistry (76 citations), Biochemistry (72 citations), Biochemistry (45 citations) and Applied Microbiology and Biotechnology (12 citations). Orhan Adalı has collaborated with scholars based in Türkiye, Serbia and United Kingdom. Frequent co-authors include Emel Arınç, Serdar Karakurt, Birsen Can Demirdöğen, Şeref Demirkaya, Şevki Arslan, Semai Bek, Alaattin Şen, Aslı Semiz, Ayşe Mine Gençler Özkan and Azra Bozcaarmutlu. Their work appears in journals such as Neurological Sciences, Archives of Toxicology, Cell Biochemistry and Function, Neurological Research and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.